-
EP4098271
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4098271
| EP4098271 - PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING WEISSELLA CIBARIA WIKIM28 AS ACTIVE INGREDIENT [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 04.11.2022 Database last updated on 10.07.2024 | |
| Former | The international publication has been made Status updated on 06.08.2021 | Most recent event Tooltip | 09.07.2024 | The date on which the examining division becomes responsible, has been established | 09.07.2024 | Amendment by applicant | Applicant(s) | For all designated states Liscure Biosciences Co., Ltd. 7F(Sinsa-dong, M.I. Tower Building) 626, Gangnam-daero Gangnam-gu Seoul 06035 / KR | [2022/49] | Inventor(s) | 01 /
CHIN, Hwa Sup 303ho, 103dong, Samsung Sherville 60, Gogi-ro 67beon-gil Suji-gu Yongin-si Gyeonggi-do 16824 / KR | [2022/49] | Representative(s) | Cabinet Becker et Associés 25, rue Louis le Grand 75002 Paris / FR | [2022/49] | Application number, filing date | 21747952.6 | 27.01.2021 | [2022/49] | WO2021KR01059 | Priority number, date | KR20200012144 | 31.01.2020 Original published format: KR 20200012144 | KR20200056138 | 11.05.2020 Original published format: KR 20200056138 | [2022/49] | Filing language | KO | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021153980 | Date: | 05.08.2021 | Language: | KO | [2021/31] | Type: | A1 Application with search report | No.: | EP4098271 | Date: | 07.12.2022 | Language: | EN | [2022/49] | Search report(s) | International search report - published on: | KR | 05.08.2021 | (Supplementary) European search report - dispatched on: | EP | 30.01.2024 | Classification | IPC: | A61K35/741, A61P35/00, A23L33/135, A23K10/18 | [2024/09] | CPC: |
A23L33/135 (EP);
A61K35/747 (US);
A23K10/16 (EP);
A23K10/18 (EP);
A23K50/10 (EP);
A23K50/20 (EP);
A23K50/30 (EP);
A23K50/40 (EP);
A23K50/75 (EP);
A23K50/80 (EP);
A61K35/744 (EP);
A61P35/00 (EP,US);
C12N1/205 (US);
A23V2002/00 (EP);
A61K2035/115 (US);
C12R2001/01 (US)
(-)
| C-Set: |
A23V2002/00, A23V2200/3204, A23V2200/308 (EP)
|
| Former IPC [2022/49] | A61K35/74, A61P35/00, A23L33/135, A23K10/16 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/49] | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUM VORBEUGEN ODER BEHANDELN VON KREBS, MIT WEISSELLA CIBARIA WIKIM28 ALS WIRKSTOFF | [2022/49] | English: | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING WEISSELLA CIBARIA WIKIM28 AS ACTIVE INGREDIENT | [2022/49] | French: | COMPOSITION PHARMACEUTIQUE POUR LA PRÉVENTION OU LE TRAITEMENT DU CANCER, COMPRENANT WEISSELLA CIBARIA WIKIM28 EN TANT QUE PRINCIPE ACTIF | [2022/49] | Biological material | This application mentions deposited biological material, check the file for details | Entry into regional phase | 27.07.2022 | Translation filed | 27.07.2022 | National basic fee paid | 27.07.2022 | Search fee paid | 27.07.2022 | Designation fee(s) paid | 27.07.2022 | Examination fee paid | Examination procedure | 27.07.2022 | Examination requested [2022/49] | 08.07.2024 | Amendment by applicant (claims and/or description) | 08.07.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 08.03.2023 | Renewal fee patent year 03 | 26.01.2024 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.01.2023 | 03 M06 Fee paid on 08.03.2023 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]KR20100074928 (KOREA FOOD RES INST [KR]) [Y] 1-15 * the whole document *; | [Y]KR101834383B (KOREA FOOD RES INST [KR]) [Y] 1-15 * the whole document *; | [XP]WO2020122484 (KOREA FOOD RES INST [KR]) [XP] 1-15 * the whole document *; | [Y] - SHIN-HYE KWAK ET AL, "Cancer Preventive Potential of Kimchi Lactic Acid Bacteria (Weissella cibaria, Lactobacillus plantarum)", JOURNAL OF CANCER PREVENTION, KR, (20141230), vol. 19, no. 4, doi:10.15430/JCP.2014.19.4.253, ISSN 2288-3649, pages 253 - 258, XP055716159 [Y] 1-15 * page 255 * DOI: http://dx.doi.org/10.15430/JCP.2014.19.4.253 | [Y] - LIM SEUL KI ET AL, "Weissella cibaria WIKIM28 ameliorates atopic dermatitis-like skin lesions by inducing tolerogenic dendritic cells and regulatory T cells in BALB/c mice", vol. 7, no. 1, doi:10.1038/srep40040, (20170201), SCIENTIFIC REPORTS, URL: https://www.nature.com/articles/srep40040.pdf, XP055835512 [Y] 1-15 * page 6 * DOI: http://dx.doi.org/10.1038/srep40040 | International search | [X]KR20100074928 (KOREA FOOD RES INST [KR]) [X] 1-15 * See abstract; and experimental examples 1 and 5. *; | [A]KR20160023457 (DAYOU WINIA CO LTD [KR]) [A] 1-15* See entire document. *; | [DX]KR102009742B (KOREA FOOD RES INST [KR]) [DX] 1-15 * See paragraphs [0010]-[0014] and [0019]-[0027]. *; | [X] - Shin-Hye Kwak, Et Al., "Cancer Preventive Potential of Kimchi Lactic Acid Bacteria (Weissella cibaria, Lactobacillus plantarum)", Journal of Cancer Prevention, Korean Society of Cancer Prevention, KR, KR, (20141230), vol. 19, no. 4, doi:10.15430/JCP.2014.19.4.253, ISSN 2288-3649, pages 253 - 258, XP055716159 [X] 1-15 * See abstract; and pages 255-256. * DOI: http://dx.doi.org/10.15430/JCP.2014.19.4.253 | [A] - Anonymous, "Weissella cibaria strain WIKIM28 16S ribosomal RNA gene, partial seque", Nucleotide, (20160630), Database accession no. KU555931, URL: NCBI, XP055716153 [A] 1-15 * See entire document. * | by applicant | KR102009742B | - Remington's Pharmaceutical Science, Mack Publishing Company |